Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
nash
2
×
national
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
ad-comm
aducanumab
affimed
affordable care act
akcea therapeutics
aldeyra therapeutics
alex azar
allogene therapeutics
alzheimer's disease
What
bio
2
×
roundup
aducanumab
allogene
alzheimer’s
amyloid
angst
bagged
billions
biogen
biogen’s
brammer
cancer
crispr
diversity
drug
effects
failure
felt
hot
immunotherapy
investors
ipo
juno
lost
million
nash
nearly
new
news
remains
ripple
shares
snapped
therapeutics
ticket
utero
week
years
Language
Current search:
nash
×
bio
×
biogen
×
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More